Hormonal regulation of apolipoprotein AI

Journal of Molecular Endocrinology

Volumn 22, Issue 2, 1999, Pages 103-111

  Hargrove, G M ^a   Junco, A ^a   Wong, N C W ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; APOLIPOPROTEIN A1; DEXAMETHASONE; ESTRADIOL; GLUCOCORTICOID; HORMONE RECEPTOR; LIGAND; RETINOIC ACID; SEX HORMONE; STEROID; THYROID HORMONE;

CHOLESTEROL METABOLISM; GENE ACTIVITY; HORMONAL REGULATION; HORMONE ACTION; HUMAN; LIPID METABOLISM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; THYROID FUNCTION; TRANSCRIPTION REGULATION;

EID: 0032963782     PISSN: 09525041     EISSN: None     Source Type: Journal    
DOI: 10.1677/jme.0.0220103     Document Type: Review

References (93)

1. Abrams J & Grundy S 1981 Cholesterol metabolism in hypothyroidism and hyperthyroidism in man. Journal of Lipid Research 22 323-338.
2. Abrams JJ, Grundy SM & Ginsberg H 1981 Metabolism of plasma triglyceride in hypothyroidism and hyperthyroidism in man. Journal of Lipid Research 22 307-322.
3. Apostolopoulos JJ, Howlett GJ & Fidge N 1987 Effects of dietary cholesterol and hypothyroidism on rat apolipoprotein mRNA metabolism. Journal of Lipid Research 28 642-648.
4. Applebaum-Bowden D, McLean P, Steinmetz A, Fontana D, Matthys C, Warnick GR, Cheung M, Albers JJ & Hazzard WR 1989 Lipoprotein, apolipoprotein, and lipolytic enzyme changes following estrogen administration in postmenopausal women. Journal of Lipid Research 30 1895-1906.
5. Archer TK, Tam SP & Deeley RG 1986 Kinetics of estrogen-dependent modulation of apolipoprotein A-I synthesis in human hepatoma cells. Journal of Biological Chemistry 261 5067-5074.
6. Ashley JM, Lowe NJ, Borok ME & Alfin-Slater RB 1988 Fish oil supplementation results in decreased hypertriglyceridemia in patients with psoriasis undergoing etretinate or acitretin therapy. Journal of the American Academy of Dermatology 19 76-82.
7. Aviram M, Luboshitzky R & Brooks JG 1982 Lipid and lipoprotein pattern in thyroid dysfunction and the effect of therapy. Clinical Biochemistry 15 62-66.
8. Ballantyne FC, Eppentos AA, Caslake M, Forsthe S & Ballantyne D 1979 The composition of LDL, and VLDL subfractions in primary hypothyroidism and the effects of thyroid hormone replacement therapy. Clinical Science 57 83-88.
9. Ballantyne FC, Clark RS, Simpson HS & Ballantyne D 1982 The effect of moderate physical exercise on the plasma lipoprotein subfractions of male survivors of myocardial infarction. Circulation 65 913-918.
10. Barter PJ & Rye KA 1996 Molecular mechanisms of reverse cholesterol transport. Current Opinion In Lipidology 7 82-87.
11. Beato M, Herrlich P & Schultz G 1995 Steroid hormone receptors: many actors in search of a plot. Cell 83 851-857.
12. Berthou L, Staels B, Saldicco I, Berthelot K, Casey J, Fruchart J-C, Denefle P & Branellec D 1994 Opposite in vitro and in vivo regulation of hepatic apolipoprotein AI gene expression by retinoic acid. Arteriosclerosis and Thrombosis 14 1657-1664.
13. Brun L, Gagne C, Coulombe P, Lupien P, Dussault H & Moorjani S 1980 Effects of dextrothyroxine on the pituitary-thyroid axis in hypercholesterolemic children and goitrous adults. Journal of Clinical Endocrinology and Metabolism 51 1306-1310.
14. Carr FE & Wong NCW 1994 Characteristics of a negative thyroid hormone response element (TRE). Journal of Biological Chemistry 269 4175-4179.
15. Carr FE, Kaseem LL & Wong NCW 1992 Thyroid hormone inhibits TSH gene expression via a position independent negative T3RE. Journal of Biological Chemistry 267 18689-18694.
16. Chan J, Nakabayashi H & Wong NCW 1993 HNF-4 increases rat apolipoprotein A1 gene expression. Nucleic Acids Research 21 1205-1211.
17. Colvin PL, Auerbach BJ, Case D, Hazzard WR & Applebaum-Bowden D 1991 A dose - response relationship between sex hormone-induced change in hepatic triglyceride lipase and high-density lipoprotein cholesterol in postmenopausal women. Metabolism 40 1052-1056.
18. Croston GE, Milan LB, Marschke KB, Reichman M & Briggs MR 1997 Androgen receptor-mediated antagonism of estrogen-dependent low density lipoprotein receptor transcription in cultured hepatocytes. Endocrinology 138 3779-3786.
19. Danner SA, Wieling W, Havekes L, Leuven JG, Smit EM & Dunning AJ 1984 Effect of physical exercise on blood lipids and adipose tissue composition in young healthy men. Atherosclerosis 53 83-90.
20. Elshourbagy NA, Boguski MS, Liao WS, Jefferson LS, Gordon JI & Taylor JM 1985 Expression of rat apolipoprotein A-IV and A-I genes: mRNA induction during development and in response to glucocorticoids and insulin. Proceedings of the National Academy of Sciences of the USA 82 8242-8246.
21. Engelken SF & Eaton RP 1980 Thyroid hormone induced dissociation between plasma triglyceride and cholesterol regulation in the rat. Endocrinology 107 208-214.
22. Ettinger WH, Klinefelter HF & Kwiterovitch PO 1987 Effect of short-term, low-dose corticosteroids of plasma lipoprotein lipids. Atherosclerosis 63 167-172.
23. Feely J, Iqbal S, Isles T & Bakry M 1980 Total cholesterol in/HDL-cholesterol ratio in hyperthyroidism, hypothyroidism and subclinical hypothyroidism. Hormone Research 12 560-561.
24. Franceschini G, Maderna P & Sirtori CR 1991 Reverse cholesterol transport: physiology and pharmacology. Atherosclerosis 88 99-107.
25. Fuernkranz HA, Wang Y, Karathanasis SK & Mak P 1994 Transcriptional regulation of the apoAI gene by hepatic nuclear factor 4 in yeast. Nucleic Acids Research 25 5665-5671.
26. Giller T, Hennes U & Kempen HJ 1995 Regulation of human apolipoprotein AI expression in Caco-2 and HepG2 cells by all-trans and 9-cis retinoic acids. Journal of Lipid Research 36 1021-1028.
27. Ginsburg GS, Ozer J & Karathanasis SK 1995 Intestinal apolipoprotein AI gene transcription is regulated by multiple distinct DNA elements and is synergistically activated by the orphan nuclear receptor, hepatocyte nuclear factor 4. Journal of Clinical Investigation 96 528-538.
28. Godsland IF, Wynn V, Crook D & Miller NE 1987 Sex, plasma lipoprotein, and atherosclerosis: prevailing assumptions and outstanding questions. American Heart Journal 114 1467-1503.
29. Harnish DC, Malik S & Karathanasis SK 1994 Activation of apolipoprotein AI gene transcription by the liver-enriched factor HNF-3. Journal of Biological Chemistry 269 28220-28226.
30. Harnish DC, Malik S, Kilbourne E, Costa R & Karathanasis SK 1996 Control of apolipoprotein AI gene expression through synergistic interactions between hepatocyte nuclear factors 3 and 4. Journal of Biological Chemistry 271 13621-13628.
31. Harnish DC, Evans MJ, Scicchitano MS, Bhat RA & Karathanasis SK 1998 Estrogen regulation of the apolipoprotein AI gene promoter through transcription factor sharing. Journal of Biological Chemistry 273 9270-9278.
32. Hazzard WR, Haffner SM, Kushwaha RS, Aplebaum-Bowden D & Foster DM 1984 Preliminary report: kinetic studies on the modulation of HDL, apolipoprotein, and subfraction metabolism by sex steroids in a postmenopausal woman. Metabolism: Clinical and Experimental 33 779-789.
33. Heiss G, Johnson J, Reilan S, Dais CE & Tyroler HA 1980 The epidemiology of plasma HDL cholesterol levels. Circulation 62 IV116-IV136.
34. Huttunen JK, Lansimies E, Voutilainen E, Ehnholm C, Hietanen E, Penttila I, Siitonen O & Rauramaa R 1979 Effect of moderate physical exercise on serum lipoproteins. A controlled clinical trial with special reference to serum high-density lipoproteins. Circulation 60 1220-1229.
35. Jin FY, Kamanna VS & Kashyap ML 1998 Estradiol stimulates apolipoprotein A-I- but not A-II-containing particle synthesis and secretion by stimulating mRNA transcription rate in Hep G2 cells. Arteriosclerosis Thrombosis and Vascular Biology 18 999-1006.
36. Kalin MC & Zumoff B 1990 Sex hormones and coronary disease: a review of the clinical studies. Steroids 55 331-353.
37. Kaptein A, de Wit EC & Princen HM 1994 Retinoids stimulate ApoAI synthesis by induction of gene transcription in primary hepatocyte cultures from cynomolgus monkey (Macaca fascicularis). Arteriosclerosis and Thrombosis 13 1505-1514. Erratum 14 839.
38. Kashyap ML 1989 Basic considerations in the reversal of atherosclerosis: significance of HDL in stimulating reverse cholesterol transport. American Journal of Cardiology 63 56H-59H.
39. Kaste M, Muuronen A, Nikkila EA & Neuvonen PJ 1983 Increase of low serum concentrations of HDL cholesterol in TIA-patients treated with phenytoin. Stroke 4 525-530.
40. Kris-Etherton P, Fosmire M, Mela D & Etherton T 1982 Studies on the etiology of increased tissue cholesterol concentration in cholesterol-fed hypothyroid rats. Journal of Nutrition 112 2324-2332.
41. Ladias JAA & Karathanasis SK 1991 Regulation of the apolipoprotein AI gene by ARP-1, a novel member of the steroid receptor superfamily. Science 251 561-565.
42. Larosa JC 1995 Androgens and women's health: genetic and epidemiologic aspects of lipid metabolism. American Journal of Medicine 98 22S-26S.
43. Laudet V 1997 Evolution of the nuclear receptor superfamily: early diversification from an ancestral orphan receptor. Journal of Molecular Endocrinology 19 207-226.
44. Luoma PV 1997 Gene activation, apolipoprotein A-I/high density lipoprotein, atherosclerosis prevention and longevity. Pharmacology and Toxicology 81 57-64.
45. McConnell MV, Vavouranakis I, Wu LL, Vaughan DE & Ridker PM 1997 Effects of a single, daily alcoholic beverage on lipid and hemostatic markers of cardiovascular risk. American Journal of Cardiology 80 1226-1228.
46. Malik K & Karathanasis SK 1996 TFIIB-directed transcriptional activation by the orphan nuclear receptor hepatocyte nuclear factor 4. Molecular and Cellular Biology 16 1824-1831.
47. Malkonen M & Manninen V 1981 Failure of thyroid hormones to maintain the normal lipoprotein pattern in rats after removal of the pituitary gland. Atherosclerosis 38 121-128.
48. Manttari M, Tenkanen L, Alikoski T & Manninen V 1997 Alcohol and coronary heart disease: the roles of HDL-cholesterol and smoking. Journal of Internal Medicine 241 157-163.
49. Mason RL, Hunt HM & Hurxthal L 1930 Blood cholesterol values in hyperthyroidism and hypothyroidism - their significance. New England Journal of Medicine 203 1273-1277.
50. Masumoto A, Koga S, Uchida E & Ibayashi H 1988 Effects of insulin, dexamethasone and glucagon on the production of apolipoprotein AI in cultured rat hepatocytes. Atherosclerosis 70 217-223.
51. Melnik BC, Bros U & Plewig G 1987 Evaluation of the atherogenic risk of isotretinoin-induced and etretinate-induced alterations of lipoprotein cholesterol metabolism. Journal of Investigative Dermatology 88 39S-43S.
52. Miettinen TA 1968 Mechanism of serum cholesterol reduction by thyroid hormones in hypothyroidism. Journal of Laboratory and Clinical Medicine 71 537-547.
53. Miller NE 1987 Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis. American Heart Journal 113 589-597.
54. Miller NE, Laville A & Crook D 1985 Direct evidence that reverse cholesterol transport is mediated by high-density lipoprotein in rabbit. Nature 314 109-111.
55. Mooradian AD, Shuh GN & Wong NCW 1996 Age-related changes in the responsiveness of apolipoprotein AI to thyroid hormone. American Journal of Physiology 271 R1602-R1607.
56. Murao K, Bassyouni H, Taylor AH, Wanke IE & Wong NCW 1997 Hepatocyte nuclear factor 4 inhibits the activity of site A from the rat apolipoprotein gene. Biochemistry 36 301-306.
57. Murray CJL & Lopez AD 1997 Mortality by cause for eight regions of the world: global burden of disease study. Lancet 349 1469-1504.
58. Muuronen A, Kaste M, Nikkila EA & Tolppanen EM 1985 Mortality from ischaemic heart disease among patients using anticonvulsive drugs: a case - control study. British Medical Journal of Clinical Research and Education 291 1481-1483.
59. Naar AM, Boutin JM, Lipkin SM, Yu VC, Holloway JM, Glass CK & Rosenfeld MG 1991 The orientation and spacing of core DNA-binding motifs dictate selective transcriptional response to three nuclear receptors. Cell 65 1267-1280.
60. Nagasaki A, Kikuchi T, Kurata K, Masushige S, Hasegawa T & Kato S 1994 Vitamin A regulates the expression of apolipoprotein AI and CIII genes in the rat. Biochemical and Biophysical Research Communications 205 1510-1517.
61. Nakabayashi HK, Watanabe A, Saito A, Otsuru K, Sawadaishi K & Tamaoki T 1989 Transcriptional regulation of alpha-fetoprotein expression by dexamethasone in human hepatoma cells. Journal of Biological Chemistry 264 266-271.
62. Nikkila EA, Kaste M, Ehnholm C & Viikari J 1978 Elevation of high-density lipoprotein in epileptic patients treated with phenytoin. Acta Medica Scandinavica 204 517-520.
63. O'Hara D, Porte D & Williams RH 1966 The effect of diet and thyroxin on plasma lipids in myxedema. Metabolism 15 123-134.
64. Quintao ECR, Nakandakare E, Oliveira HCF, Rocha JC, Garcia RC & Melo NR 1991 Oral estradiol-17beta raises the level of plasma high-density lipoprotein in menopausal women by slowing down its clearance rate. Acta Endocrinologica 125 657-661.
65. Raziel A, Rosenzweig B, Botvinic V, Beigel F, Landau B & Blum I 1982 The influence of thyroid function on serum lipid profile. Atherosclerosis 41 321-326.
66. Reddy MN 1985 Effect of anticonvulsant drugs on plasma total cholesterol, high-density lipoprotein cholesterol, and apolipoproteins A and B in children with epilepsy. Proceedings of the Society for Experimental Biology and Medicine 180 359-363.
67. Romney JS, Chan J, Carr FE, Mooradian AD & Wong NCW 1992 Identification of the thyroid hormone mRNA Spot 11 as apolipoprotein AI mRNA and effects of the hormone on the promoter. Molecular Endocrinology 6 943-950.
68. Rossner S & Rosenqvist U 1974 Serum lipoprotems and the intravenous fat tolerance test in hypothyroid patients before and during substitution therapy. Atherosclerosis 20 365-381.
69. Rottman JN, Widom RL, Nadal-Ginard B, Mahdavi V & Karathanasis SK 1991 A retinoic acid-responsive element in the apolipoprotein gene distinguishes between two different retinoic acid response pathways. Molecular and Cellular Biology 11 3814-3820.
70. Sacks FM, Gerhard M & Walsh BW 1995 Sex hormones, lipoproteins, and vascular reactivity. Current Opinion in Lipidology 6 161-166.
71. Saladin R, Vu-Dac N, Fruchart J-C, Auwerx J & Staels B 1996 Transcriptional induction of rat liver apolipoprotein A-I gene expression by glucocorticoids requires the glucocorticoid receptor and a labile cell-specific protein. European Journal of Biochemistry 239 451-459.
72. Schaefer EJ, Foster DM, Zech LA, Lindgren FT, Brewer B & Levy RI 1983 The effects of estrogen administration on plasma lipoprotein metabolism in premenopausal females. Journal of Clinical Endocrinology and Metabolism 57 262-266.
73. Scottolini A, Bhagavan N, Oshiro T & Abe S 1980 Serum HDL cholesterol concentrations in hypo- and hyperthyroidsm. Clinical Chemistry 26 584-587.
74. Seishima M, Bisgaier CL, Davies SL & Glickman RM 1991 Regulation of hepatic apolipoprotein synthesis in the I 7alpha-ethinyl estradiol-treated rat. Journal of Lipid Research 32 941-951.
75. Sladek FM, Zhong W, Lai E & Darnell JE 1991 Liver-enriched transcription factor HNF-4 is a novel member of the steroid hormone receptor superfamily. Genes and Development 4 2352-2365.
76. Smith LC, Pownall, HJ & Gotto AM Jr 1978 The plasma lipoproteins: structure and metabolism. Annual Review of Biochemistry 47 751-777.
77. Srivastava RAK, Baumann D & Schonfeld G 1993 In vivo regulation of low-density lipoprotein receptors by estrogen differs at the post-transcriptional level in rat and mouse. European Journal of Biochemistry 216 527-538.
78. Staels B, van Tol A, Chan L, Verhoeven G & Auwerx J 1991 Variable effects of different corticosteroids on plasma lipids, apolipoproteins, and hepatic apolipoprotein mRNA levels in rats. Arteriosclerosis and Thrombosis 11 760-769.
79. Strobl W, Gorder NL, Lui-Lee YC, Gotto AM & Patsch W 1990 Role of thyroid hormone in apolipoprotein AI gene expression in rat liver. Journal of Clinical Investigation 85 659-667.
80. Tam SP, Archer TK & Deeley RG 1985 Effects of estrogen on apolipoprotein secretion by the human hepatocarcinoma cell line, HepG2. Journal of Biological Chemistry 260 1670-1675.
81. Tam SP, Archer TK & Deeley RG 1986 Biphasic effects of estrogen on apolipoprotein synthesis in human hepatoma cells: mechanism of antagonism by testosterone. Proceedings of the National Academy of Sciences of the USA 83 3111-3115.
82. Tang J, Ajit K, Srivastava ES, Baumann D, Pfleger BA, Kitchens RT & Schonfeld G 1991 In vivo regulation of apolipoprotein gene expression by estradiol and testosterone occurs by different mechanisms in inbred strains of mice. Journal of Lipid Research 32 1571-1586.
83. Taylor AH, Raymond J, Dionne JM, Romney J, Chan J, Lawless DE, Wanke IE & Wong NCW 1996a Glucocorticoid increases rat apolipoprotein AI promoter activity. Journal of Lipid Research 37 2232-2243.
84. Taylor AH, Wishart P, Lawless DE, Raymond J & Wong NCW 1996b Identification of functional positive and negative thyroid hormone-responsive elements in the rat apolipoprotein AI promoter. Biochemistry 35 8281-8288.
85. Taylor AH, Stephan ZF, Steele RE & Wong NCW 1997 Beneficial effects of a novel thyromimetic on lipoprotein metabolism. Molecular Pharmacology 52 542-547.
86. Umesono K, Murakami KK, Thompson CC & Evans RM 1991 Direct repeats as selective response elements for the thyroid hormone, retinoic acid and vitamin D3 receptors. Cell 65 1255-1266.
87. Valdemarsson S 1983 Plasma lipoprotein alterations in thyroid dysfunction. Acta Endocrinologica 255 1-52.
88. Vandenbrouck Y, Janvier B, Loriette C, Bereziat G & Mangeney-Andreani M 1995 Thyroid hormone modulates apolipoprotein-AI gene expression at the post-transcriptional level in Hep G2 cells. European Journal of Biochemistry 231 126-132.
89. Varma VK, Smith TK, Sorci-Thomas M & Ettinger WH 1992 Dexamethasone increases apolipoprotein AI concentrations in medium and apolipoprotein AI mRNA abundance from HepG2 cells. Metabolism 41 1075-1080.
90. Wahlqrist ML, Fidge NH & Lomas J 1977 Lipoprotein composition in hypothyroidism. Clinica Chimica Acta 77 269-274.
91. Windler EET, Kovanen PT, Chao YS, Brown MS, Havel RJ & Goldstein JL 1980 The estradiol-stimulated lipoprotein receptor of rat liver. Journal of Biological Chemistry 255 10464-10471.
92. Wong NCW & Oppenheimer JH 1986 Multihormonal regulation and kinetics of induction of a hepatic mRNA sequence which is slowly responsive to triiodothyronine. Journal of Biological Chemistry 261 10387-10393.
93. Zech LA, Gross EG, Peck GL & Brewer HB 1983 Changes in plasma cholesterol and triglyceride levels after treatment with oral iso-tretinoin. Archives of Dermatology 119 987-993.